Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.1.1.13 extracted from

  • Chiou, S.Y.; Lai, G.W.; Lin, L.Y.; Lin, G.
    Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro (2006), Indian J. Biochem. Biophys., 43, 52-55.
    View publication on PubMed
Search for more literature for 3.1.1.13

Application

Application Comment Organism
medicine lowering of cholesterol levels in plasma low-density lipoprotein by cardiovascular drugs such as lovastatin, simvastatin, amlodipine, besylate, nifedipine, and hydralazine hydrochloride may result from inhibition of cholesterol esterase Bos taurus

Inhibitors

Inhibitors Comment Organism Structure
amlodipine mixed-type, study on kinetics in presence of Triton X-100 or taurocholate Bos taurus
besylate mixed-type, study on kinetics in presence of Triton X-100 or taurocholate Bos taurus
hydralazine hydrochloride mixed-type, study on kinetics in presence of Triton X-100 or taurocholate Bos taurus
lovastatin mixed-type, study on kinetics in presence of Triton X-100 or taurocholate Bos taurus
additional information pKi values of cardiovascular drug inhibitors such as lovastatin, simvastatin, amlodipine, besylate, nifedipine, and hydralazine hydrochloride correlate with their molecular weight Bos taurus
nifedipine mixed-type, study on kinetics in presence of Triton X-100 or taurocholate Bos taurus
simvastatin mixed-type, study on kinetics in presence of Triton X-100 or taurocholate Bos taurus

Organism

Organism UniProt Comment Textmining
Bos taurus
-
-
-